Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

814
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
814
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

832
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
832
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

127
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
127
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

101
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
101
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

81
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
81

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chain-Length-Dependent Correlated Molecular Motion in Polymers.

Physical review letters·2025
Same author

Hybrid biocomposites: From molecular behaviour to material properties in silk fibroin/cellulose films.

International journal of biological macromolecules·2025
Same author

The impact of whole-molecule disorder on spin-crossover in a family of isomorphous molecular crystals.

Chemical science·2025
Same author

Editorial: Systems biology approaches to psychiatric and psychological disorders: unraveling the complexities.

Frontiers in genetics·2025
Same author

Understanding the Dissolution of Cellulose and Silk Fibroin in 1-ethyl-3-methylimidazolium Acetate and Dimethyl Sulphoxide for Application in Hybrid Films.

Materials (Basel, Switzerland)·2024
Same author

G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.

International journal of molecular sciences·2024
Same journal

Covalent character of Cellobiose-Water hydrogen bonds revealed by ELF and QTAIM for enhanced dewatering and reactivity.

Journal of molecular graphics & modelling·2026
Same journal

Residue-level insights into SGLT2 inhibition and Nav1.5 selectivity of gliflozin derivatives: A molecular dynamics and pharmacophore-guided study.

Journal of molecular graphics & modelling·2026
Same journal

A benchmarking-informed structure-based virtual screening strategy targeting Lm-PTR1: Leveraging the Northern African natural products database.

Journal of molecular graphics & modelling·2026
Same journal

In Silico identification of natural and synthetic inhibitors targeting KRAS mutants (G12D, G12V, and G12C) and wild-type in pancreatic cancer.

Journal of molecular graphics & modelling·2026
Same journal

Structural evolution, mechanical and thermal stability of 7-40 mol% yttria-stabilized zirconia: First-principles investigation.

Journal of molecular graphics & modelling·2026
Same journal

Halide-encapsulated C<sub>24</sub> fullerenes as molecular redox hosts for alkali metals: A density functional theory study.

Journal of molecular graphics & modelling·2026
See all related articles

Related Experiment Video

Updated: Aug 1, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K

Structure-based pharmacophore modeling 2. Developing a novel framework for structure-based pharmacophore model

Gregory L Szwabowski1, Bernie J Daigle2, Daniel L Baker1

  • 1Department of Chemistry, The University of Memphis, Memphis, TN, 38152, USA.

Journal of Molecular Graphics & Modelling
|April 30, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces a novel structure-based pharmacophore modeling method using Multiple Copy Simultaneous Search (MCSS) fragments for G protein-coupled receptors (GPCRs). The approach effectively generates and selects high-quality pharmacophore models for drug discovery.

Keywords:
GPCRLigand discoveryLigand identificationPharmacophore modelingStructure-based pharmacophore

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.9K
NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.3K

Related Experiment Videos

Last Updated: Aug 1, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.9K
NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.3K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Structural biology

Background:

  • Pharmacophore models are crucial for identifying drug candidates targeting G protein-coupled receptors (GPCRs).
  • Many GPCRs lack known ligands or structures, hindering traditional pharmacophore model generation.
  • Existing methods struggle with generating accurate models for these challenging targets.

Purpose of the Study:

  • To develop a robust structure-based pharmacophore modeling approach for GPCRs.
  • To address the challenge of selecting effective pharmacophore models.
  • To improve ligand identification for GPCR drug development.

Main Methods:

  • Utilized Multiple Copy Simultaneous Search (MCSS) to place fragments and generate structure-based pharmacophore models.
  • Applied a cluster-then-predict machine learning workflow for pharmacophore model selection.
  • Generated models using both experimentally determined and homology-modeled GPCR structures.

Main Results:

  • Generated pharmacophore models for 13 class A GPCRs, achieving high enrichment factors in ligand database searches.
  • The machine learning classifier demonstrated strong performance in selecting high-enrichment pharmacophore models.
  • Achieved positive predictive values of 0.88 and 0.76 for models from experimental and modeled structures, respectively.

Conclusions:

  • The proposed structure-based pharmacophore modeling approach effectively generates high-quality models for GPCRs.
  • The machine learning-based selection workflow significantly improves the identification of relevant pharmacophore models.
  • This method offers a valuable tool for GPCR-focused drug discovery, even with limited structural data.